Graham-Brown Matthew P M, Adenwalla Sherna F, Lai Florence Y, Hunt William H, Parke Kelly, Gulsin Gaurav, Burton James O, McCann Gerry P
John Walls Renal Unit, University Hospitals Leicester NHS Trust, Leicester, UK.
Department of Infection Immunity and Inflammation, School of Medicine and Biological Sciences, University of Leicester, Leicester, UK.
Clin Kidney J. 2018 Dec;11(6):864-873. doi: 10.1093/ckj/sfy042. Epub 2018 Jun 21.
Aortic stiffness is one of the earliest signs of cardiovascular disease (CVD) in patients with chronic kidney disease and an independent predictor of mortality. It is thought to drive left ventricular (LV) remodelling, an established biomarker for mortality. The relationship between direct and indirect measures of aortic stiffness and LV remodelling is not defined in dialysis patients, nor are the reproducibility of methods used to assess aortic stiffness using cardiac magnetic resonance (CMR) imaging.
Using 3T CMR, we report the results of (i) the interstudy, interobserver and intra-observer reproducibility of ascending aortic distensibility (AAD), descending aortic distensibility (DAD) and aortic pulse wave velocity (aPWV) in 10 haemodialysis (HD) patients and (ii) the relationship between AAD, DAD and aPWV and LV mass index (LVMi) and LV remodelling in 70 HD patients.
Inter- and intra-observer variability of AAD, DAD and aPWV were excellent [intraclass correlation (ICC) > 0.9 for all]. Interstudy reproducibility of AAD was excellent {ICC 0.94 [95% confidence interval (CI) 0.78-0.99]}, but poor for DAD and aPWV [ICC 0.51 (-0.13-0.85) and 0.51 (-0.31-0.89)]. AAD, DAD and aPWV associated with LVMi on univariate analysis (β = -0.244, P = 0.04; β =-0.315, P < 0.001 and β = 0.242, P = 0.04, respectively). Only systolic blood pressure, serum phosphate and a history of CVD remained independent determinants of LVMi on multivariable linear regression.
AAD is the most reproducible CMR-derived measure of aortic stiffness in HD patients. CMR-derived measures of aortic stiffness were not independent determinants of LVMi in HD patients. Whether one should target blood pressure over aortic stiffness to mitigate cardiovascular risk still needs determination.
主动脉僵硬度是慢性肾脏病患者心血管疾病(CVD)最早的迹象之一,也是死亡率的独立预测因素。它被认为会驱动左心室(LV)重构,这是一种已确立的死亡率生物标志物。在透析患者中,主动脉僵硬度的直接和间接测量与LV重构之间的关系尚未明确,使用心脏磁共振(CMR)成像评估主动脉僵硬度的方法的可重复性也未明确。
使用3T CMR,我们报告了(i)10例血液透析(HD)患者升主动脉扩张性(AAD)、降主动脉扩张性(DAD)和主动脉脉搏波速度(aPWV)的研究间、观察者间和观察者内的可重复性,以及(ii)70例HD患者中AAD、DAD和aPWV与左心室质量指数(LVMi)和LV重构之间的关系。
AAD、DAD和aPWV的观察者间和观察者内变异性都很好(所有组内相关系数[ICC]均>0.9)。AAD的研究间可重复性很好{ICC 0.94[95%置信区间(CI)0.78 - 0.99]},但DAD和aPWV的可重复性较差[ICC 0.51(-0.13 - 0.85)和0.51(-0.31 - 0.89)]。单因素分析中,AAD、DAD和aPWV与LVMi相关(β分别为-0.244,P = 0.04;β = -0.315,P < 0.001;β = 0.242,P = 0.04)。多变量线性回归分析中,只有收缩压、血清磷酸盐和CVD病史仍是LVMi的独立决定因素。
AAD是HD患者中CMR衍生的主动脉僵硬度测量方法中可重复性最高的。CMR衍生的主动脉僵硬度测量指标不是HD患者LVMi的独立决定因素。是否应将血压而非主动脉僵硬度作为降低心血管风险的目标仍有待确定。